(Q34342960)

English

Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis (English)

1 reference

Europe PubMed Central

1 August 2017

radiation therapy

0 references

intraoperative radiation therapy

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

9

object named as

Juergen Debus

1 reference

Europe PubMed Central

1 August 2017

author name string

Falk Roeder

1

1 reference

Europe PubMed Central

1 August 2017

Carmen Timke

2

1 reference

Europe PubMed Central

1 August 2017

Matthias Uhl

3

1 reference

Europe PubMed Central

1 August 2017

Gregor Habl

4

1 reference

Europe PubMed Central

1 August 2017

Frank W Hensley

5

1 reference

Europe PubMed Central

1 August 2017

Markus W Buechler

6

1 reference

Europe PubMed Central

1 August 2017

Robert Krempien

7

1 reference

Europe PubMed Central

1 August 2017

Peter E Huber

8

1 reference

Europe PubMed Central

1 August 2017

Jens Werner

10

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

18 July 2012

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

12

1 reference

Europe PubMed Central

1 August 2017

295

1 reference

Europe PubMed Central

1 August 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-12-295

0 references

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Intraoperative radiation therapy first part: rationale and techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3414804

6 July 2018

Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

Neoadjuvant chemoradiation with tegafur in cancer of the pancreas: initial analysis of clinical tolerance and outcome

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-295

21 January 2018

High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controversies in the adjuvant treatment of pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic radiotherapy for pancreatic cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22809267

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-12-295

1 reference

Europe PubMed Central

1 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34342960&oldid=1577481115"